|
 |
Fosamax Plus DThis page contains recent news articles, when available, and an overview of Fosamax Plus D but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Fosamax, with an indication in osteoporosis Fosamax and its reformulated counter part Fosamax PLUS D which accrued combined sales of $2845m in 2005. PR-Inside.com (Pressemitteilung), Wyeth Gets Third Approvable Letter for Osteoporosis Treatment - May 30, 2008 Merck’s Fosamax (alendronate sodium) and Fosamax Plus D, used to treat or prevent postmenopausal osteoporosis, had 2007 worldwide sales of $3.05 billion, FDA news (subscription), Search By Symbol - Apr 21, 2008 In the quarter, total sales of FOSAMAX and FOSAMAX PLUS D, marketed as FOSAVANCE throughout the European Union, plunged 37% to $470 million, RTT News, Generic Fosamax on the Way - Feb 12, 2008 Merck’s other formulation of the drug, Fosamax Plus D (alendronate sodium/cholecalciferol), is expected to lose exclusivity in April. FDA news (subscription), 3 generic versions of Fosamax launched - 06 Feb 2008 Two other drugs made by Merck, called Fosamax Plus D, with different doses of vitamin D to increase calcium absorption by the bones, still have patent BusinessWeek 3 generic versions of Fosamax launched - 06 Feb 2008 Two other drugs made by Merck, called Fosamax Plus D, with different doses of vitamin D to increase calcium absorption by the bones, still have patent Forbes, Lookahead: Retail Check-Up - Feb 1, 2008 ...generic" version of Fosamax with an unidentified partner. Patent protection for a related product, Fosamax Plus D, is expected to expire in April. Wall Street Journal Merck Announces 2007 Financial Results Reflecting Revenue Growth ... - Jan 30, 2008 Worldwide sales of FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union) were $796 million for the fourth quarter of 2007, Business Wire (press release), Search By Symbol - Jan 30, 2008 Worldwide Sales of Fosamax and Fosamax Plus D improved 1% to $796 million from the similar period of last year. Fosamax and Fosamax Plus D are prescribed RTT News, Merck Plans Authorized Generic Fosamax - Jan 21, 2008 Fosamax and Fosamax Plus D (alendronate sodium/cholecalciferol) are the most prescribed treatments for osteoporosis with sales of $2.3 billion during the FDA news (subscription), Vioxx Charges Hit Merck - Jan 30, 2008 Bone-density drugs Fosamax and Fosamax Plus D accounted for $796 million in sales in the fourth quarter, an increase of 1% over the year-ago quarter. TheStreet.com FDA issues MedWatch alert on pain risks of bisphosphonates - Jan 20, 2008 The medications listed in the warning are: alendronate, or Fosamax and Fosamax Plus D; etidronate, or Didronel; ibandronate, or Boniva; pamidronate, American Medical News (subscription) Merck Q3 Profit Rises 62% On Product Sales; Adj. EPS Tops ... - Oct 22, 2007 Fosamax and Fosamax Plus D are prescribed for the treatment of osteoporosis. Sales of Merck's other promoted medicines increased 18% to $1.5 billion from RTT News, Merck's profit rises on 12% jump in sales - Oct 22, 2007 Likewise, sales of the osteoporosis drug Fosamax and Fosamax Plus D fell 6% to $725 million. Merck also provided an update on its Vioxx litigation. MarketWatch Merck Reports Double-Digit Revenue and Earnings-Per-Share Growth ... - Oct 22, 2007 Worldwide sales of FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union) were $725 million for the third quarter, representing a Business Wire (press release), Statement by Merck & Co., Inc. Regarding FOSAMAX® (alendronate sodium - Sep 18, 2007 Since their market introduction, over 225 million total prescriptions have been dispensed for FOSAMAX/FOSAMAX Plus D, Actonel (risedronate) and Boniva WebWire (press release), Buy Drugs Without Prescription. Safe and Secure Ordering. - Oct 3, 2007 ...fosamax d, fosamax plus d, geodon metabolic syndrome insilin resistance, drinking with geodon, geodon oral suspension 2007, side affects of geodon oral, LIVE-Wintersport.com, FDA - MedWatch - Early Communication Issued Regarding Atrial ... - Oct 2, 2007 There are 7 FDA-approved bisphosphonates: alendronate (Fosamax, Fosamax Plus D), etidronate (Didronel), ibandronate (Boniva), pamidronate (Aredia), PharmaLive.com (press release), Merck Reports Double-Digit Earnings-Per-Share Growth for Second ... - Jul 23, 2007 Genetic Engineering News (press release),Global sales for FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union) were $786 million for the second quarter, representing a Health Advocates Concerned as FDA Approves New Dosage Strength of ... - Jun 4, 2007 Lawyers and Settlements,Washington, DC: The FDA has approved a new dosage strength of Fosamax Plus D, despite an avalanche of lawsuits related to Fosamax and concerns among health How much calcium should a woman take? - Jun 8, 2007 Fort Wayne News Sentinel,Your once-weekly Fosamax Plus D provides vitamin D. This product comes in two formulations, one with 2800 IU of vitamin D3 and one with 5600 IU of vitamin FDA Approves New Dosage Strength Of FOSAMAX PLUS D - May 14, 2007 Compliance Home,Consistent with these recommendations, FOSAMAX PLUS D (70 mg alendronate/5600 IU vitamin D3) is now the appropriate dose for most postmenopausal patients Piribo: New Report on the Women's Health Pharmaceutical Market to 2011 - May 11, 2007 PR Web (press release),Fosamax, with an indication in osteoporosis Fosamax and its reformulated counter part Fosamax PLUS D which accrued combined sales of $2845m in 2005. Focus on the Women's Health Market to 2011 - 26 Apr 2007 PharmaLive.com (press release),Fosamax, with an indication in osteoporosis Fosamax and its reformulated counter part Fosamax PLUS D which accrued combined sales of $2845m in 2005. Merck Reports Strong Financial Results for First-Quarter 2007 - Apr 19, 2007 PharmaLive.com (press release),Global sales for FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union) were $742 million for the first quarter, representing a Merck's Q1 profit rises - Apr 20, 2007 Pharma Times (subscription),Revenues from Fosamax (alendronate) and Fosamax Plus D were less solid, faling by 2% from the previous year to $742 million. Strong Sales Of Allergic Drug Lifts Merck Q1 Profit By 12%, Sets ... - Apr 19, 2007 Trading Markets,...comparable 2006-first quarter, whereas its Fosamax and Fosamax Plus D's global sales fell 2% to $742 million from the corresponding period last year. Study Finds TV Pharma Ads Less Effective Than Print - Apr 11, 2007 MediaPost Publications,For example, 43% of people who suffer with osteoporosis recalled a TV ad for Fosamax Plus D compared with only 19% of non-sufferers. Are heartburn, osteoporosis linked? - Jan 17, 2007 Daily Press,Q: I have seen full-page ads for Fosamax Plus D in my local newspaper. Why is Merck spending so much money advertising this osteoporosis drug? Jaw Infections/Osteoporosis Drugs Nov 3, 2006 Merck, the manufacturer of FOSAMAX®, FOSAMAX Plus D™, and Boniva®, has acknowledged receiving reports of jaw osteonecrosis associated with these drugs. ... -WSOCtv.com, Merck Announces Strong Financial Results for the Third Quarter ... Oct 20, 2006 Global sales for FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union (EU)) were $771 million for the third quarter, representing a ... -PharmaLive.com (press release), Higher Persistency Rates Seen with FOSAMAX(R) Once Weekly ... Sep 19, 2006 The standard dosing regimen for FOSAMAX and FOSAMAX PLUS D(TM) includes swallowing the tablet with six to eight ounces of plain water the first thing upon ... -Business Wire Banyu Receives Japan Manufacturing Approval For Fosamax, Treatment ... Aug 5, 2006 Banyu Pharmaceutical Co., Ltd. obtained manufacturing approval for Fosamax Plus D - generic name: aledronate sodium - on July 26. ... -Medical News Today Banyu Receives Japan Manufacturing Approval for Fosamax, Treatment ... Aug 3, 2006 Tokyo, Aug 3, 2006 (JCN) - Banyu Pharmaceutical Co., Ltd. obtained manufacturing approval for Fosamax Plus D - generic name: aledronate sodium - on July 26. ... -Japan Corporate News Bone drug treatment can damage jaw Jun 26, 2006 Fosamax and Fosamax Plus D are the most widely prescribed medicines worldwide for postmenopausal, male and glucocortaid-induced osteoporosis, according to Merck ... -Monterey County Herald Merck Announces Strong Financial Results for the First Quarter ... Apr 20, 2006 FOSAMAX and FOSAMAX PLUS D (launching under the name FOSAVANCEthroughout the European Union) together remain the most-prescribedmedicine worldwide for the ... - Finanzen.net Merck Well-Positioned to Regain Industry-Leadership Position, CEO ... Apr 25, 2006 Merck received FDA approval for two new products: FOSAMAX Plus D and PROQUAD; while new indications were approved for EMEND and SINGULAIR. ... - Finanzen.net Merck Sued Over Fosamax Health Risks 11 Apr 2006 ...request, he said. Fosamax and Fosamax Plus D together are the most-prescribed medicine for osteoporosis in post-menopausal women. - Los Angeles Times Merck profits edge ahead in fourth quarter Feb 1, 2006 ...although the osteoporosis drug Fosamax (alendronate) declined 5% to $789 million, with the launch of a new formulation (Fosamax Plus D/Fosavance) failing to ... - Pharma Times (subscription), Merck Earnings Top Estimates Jan 31, 2006 12% to $819 million; sales of blood-pressure drugs Cozaar and Hyzaar rose 2% to $782 million; sales osteoporosis medication Fosamax and Fosamax Plus D fell 5 ... - TheStreet.com Merck Announces Strong Full-Year and Fourth-Quarter 2005 Earnings ... Jan 31, 2006 FOSAMAX and FOSAMAX PLUS D (launching under the name FOSAVANCE throughout the European Union) together remain the most-prescribed medicine worldwide for the ... - TMCnet Merck profits edge ahead in fourth quarter Feb 1, 2006 ...although the osteoporosis drug Fosamax (alendronate) declined 5% to $789 million, with the launch of a new formulation (Fosamax Plus D/Fosavance) failing to ... - Pharma Times (subscription) : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |